168 related articles for article (PubMed ID: 8653713)
1. Augmentation of tumor metastasis by platelet-activating factor.
Im SY; Ko HM; Kim JW; Lee HK; Ha TY; Lee HB; Oh SJ; Bai S; Chung KC; Lee YB; Kang HS; Chun SB
Cancer Res; 1996 Jun; 56(11):2662-5. PubMed ID: 8653713
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality.
Libert C; Van Molle W; Brouckaert P; Fiers W
J Inflamm; 1995-1996; 46(3):139-43. PubMed ID: 8844494
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
Chang SW
J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.
Montrucchio G; Lupia E; de Martino A; Battaglia E; Arese M; Tizzani A; Bussolino F; Camussi G
Am J Pathol; 1997 Aug; 151(2):557-63. PubMed ID: 9250168
[TBL] [Abstract][Full Text] [Related]
5. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
Xu N; Zhang XY; Dong X; Ekström U; Ye Q; Nilsson-Ehle P
Biochem Biophys Res Commun; 2002 Apr; 292(4):944-50. PubMed ID: 11944906
[TBL] [Abstract][Full Text] [Related]
6. Intrapulmonary tumor necrosis factor triggers local platelet-activating factor production in rat immune complex alveolitis.
Warren JS; Barton PA; Mandel DM; Matrosic K
Lab Invest; 1990 Dec; 63(6):746-54. PubMed ID: 2255183
[TBL] [Abstract][Full Text] [Related]
7. Glutamine inhibits platelet-activating factor-mediated pulmonary tumour metastasis.
Kim HA; Kim KJ; Yoon SY; Lee HK; Im SY
Eur J Cancer; 2012 Jul; 48(11):1730-8. PubMed ID: 21889331
[TBL] [Abstract][Full Text] [Related]
8. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
9. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G
J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
[TBL] [Abstract][Full Text] [Related]
10. Effect of platelet activating factor antagonist WEB 2086 on the production of TNF from murine peritoneal macrophages.
Ju DW; Zheng QY; Wang HB; Wang XF; Fang J
Yao Xue Xue Bao; 1993; 28(10):721-7. PubMed ID: 8009983
[TBL] [Abstract][Full Text] [Related]
11. Platelet activating factor mediates interleukin-2-induced lung injury in the rat.
Rabinovici R; Sofronski MD; Renz JF; Hillegas LM; Esser KM; Vernick J; Feuerstein G
J Clin Invest; 1992 May; 89(5):1669-73. PubMed ID: 1314853
[TBL] [Abstract][Full Text] [Related]
12. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.
Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN
Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo.
Heuer HO; Letts G; Meade CJ
J Lipid Mediat; 1990; 2 Suppl():S101-8. PubMed ID: 2133276
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice.
Giavazzi R; Garofalo A; Bani MR; Abbate M; Ghezzi P; Boraschi D; Mantovani A; Dejana E
Cancer Res; 1990 Aug; 50(15):4771-5. PubMed ID: 2196116
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions.
Piantelli M; Rossi C; Iezzi M; La Sorda R; Iacobelli S; Alberti S; Natali PG
J Cell Physiol; 2006 Apr; 207(1):23-9. PubMed ID: 16222712
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis.
He J; Bazan HE
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):883-91. PubMed ID: 16505020
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth.
Biancone L; Cantaluppi V; Del Sorbo L; Russo S; Tjoelker LW; Camussi G
Clin Cancer Res; 2003 Sep; 9(11):4214-20. PubMed ID: 14519648
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
19. Meconium enhances platelet-activating factor and tumor necrosis factor production by rat alveolar macrophages.
Berdeli A; Akisu M; Dagci T; Akisu C; Yalaz M; Kultursay N
Prostaglandins Leukot Essent Fatty Acids; 2004 Oct; 71(4):227-32. PubMed ID: 15301793
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation.
Heon Seo K; Ko HM; Kim HA; Choi JH; Jun Park S; Kim KJ; Lee HK; Im SY
Cancer Res; 2006 May; 66(9):4681-6. PubMed ID: 16651419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
